| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.49 | 0.002 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |